Cerus Corp.
NASDAQ:CERS 4:00:00 PM EDT
Market Cap (Intraday) | 297.31M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $1.73 |
50-Day MA | $2.03 |
200-Day MA | $1.91 |
Cerus Corp. Stock, NASDAQ:CERS
1220 Concord Avenue, Suite 600, Concord, California 94520
United States of America
Phone: +1.925.288.6000
Number of Employees: 288
Description
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.